Announcing termination of private equity offering which was approved by 2021 Annual Shareholders' Meeting.
· Issued by AmCad BioMed Corporation
Close
Today's Information
Provided by: AmCad BioMed Corporation
SEQ_NO
6
Date of announcement
2022/02/18
Time of announcement
16:30:25
Subject
Announcing termination of private equity offering
which was approved by 2021 Annual Shareholders' Meeting.
Date of events
2022/02/18
To which item it meets
paragraph 16
Statement
1.Date of the board of directors resolution for the change:2022/02/18
2.Effective registration date of the original plan:2021/05/21
3.Resolution date of additional issuance:N/A
4.Major change Reason for the change:
(1)The Company's 2021 Annual Shareholders' Meeting has authorized
Board of Directors to issue Private Placement Common Shares.
(2)According to Article 43-6, Securities and Exchange Law, the private
placement may be carried out by installments within one year of the
date of the resolution of the shareholders meeting. In consideration of
the capital market circumstances, the Company will not continue with
the above private placement.
5.Content of each and every successive previously changed
plan for raising of funds before and after change:N/A
6.Projected timetable for execution:N/A
7.Projected completion date:N/A
8.Projected possible benefits:N/A
9.Difference from original projected benefits:N/A
10.Effect of the current change on shareholder equity:N/A
11.Abstract of the original lead underwriter's appraisal opinion:N/A
12.Any other matters that need to be specified:None